semaglutide temporary use FDA Approval vs Compounded Alternatives Switching between weight-loss medications -

Currently under FDA review is Wegovy HD (7.2mg) and CagriSema

The 3 mg strength contains the same active medicine as higher strengths, but at a lower dose intended mainly for treatment initiation

Some insurance plans may cover tirzepatide as a preferred medication, which could lower your out-of-pocket costs, while tirzepatide may be placed on a higher drug tier, which could mean higher out-of-pocket costs, especially if it is considered a specialty medication

Semaglutide, when used with insulin secretagogues (such as sulfonylureas) or insulin, increases the risk of hypoglycemia

doi: 10.1097/ALN.0000000000000320 21 JiaYGongNLiTFZhuBWangYX